Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report
Thromb Haemost
.
2021 Jan;121(1):102-105.
doi: 10.1055/s-0040-1721486.
Epub 2020 Dec 23.
Authors
Francesco Violi
1
,
Giancarlo Ceccarelli
2
,
Lorenzo Loffredo
1
,
Francesco Alessandri
2
,
Francesco Cipollone
3
,
Damiano D'ardes
3
,
Gabriella D'Ettorre
2
,
Pasquale Pignatelli
1
,
Mario Venditti
2
,
Claudio Maria Mastroianni
2
,
Francesco Pugliese
4
Affiliations
1
I Clinica Medica, Department of Clinical Internal, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
2
Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
3
Clinica Medica, Department of Medicine and Aging, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
4
Department of Anesthesia and Critical Care Medicine, Sapienza University of Rome, Rome, Italy.
PMID:
33368057
PMCID:
PMC7869060
DOI:
10.1055/s-0040-1721486
No abstract available
Publication types
Letter
Comment
MeSH terms
Albumins
COVID-19*
Dietary Supplements
Humans
Hypoalbuminemia*
SARS-CoV-2
Thrombophilia* / drug therapy
Vascular Diseases*
Substances
Albumins